[Injective CEO Meets with White House, SEC, and CFTC to Advance Regulated On-Chain Finance] According to Jinse Finance, Injective CEO Eric Chen recently met with officials from the White House, the U.S. Securities and Exchange Commission (SEC), and the Commodity Futures Trading Commission (CFTC) to promote regulated on-chain finance in the United States. The meeting, scheduled for October 2026, was attended by other members of the company's management team, and specific outcomes were not disclosed. Discussions focused on two main themes: regulated on-chain finance and the tokenization of Real-World Assets (RWA). Injective's core qualification is its SEC registration as a transfer agent in August 2026, enabling it to maintain ownership records for tokenized securities. The company claims its on-chain tokenized RWA is worth over $1 billion, and its RWA perpetual contracts have accumulated a trading volume exceeding $5.3 billion (including stocks and commodities). In the background, Injective proposed a time-limit exemption for DeFi projects in 2025, the SEC introduced the Innovation Exemption in September 2026, and INJ futures are listed on the CFTC-regulated U.S. market by the end of 2026. The company has not announced any new approvals, and the on-chain data cited is self-reported.